logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/08/2025
The Taiwan Stock Exchange Weighted Index rose 1.2% to 23,717.35 points.
Latest
6 m ago
German Research Centre for Geosciences: 6.14 magnitude earthquake occurred east of the Thousand Islands Islands.
21 m ago
Wuhan sees a resurgence of "sunshine plate" with comprehensive measures to help the real estate market stabilize and accelerate.
21 m ago
Boan Biology independently developed the drug Dulaglutide Injection, which has been approved for market launch.
21 m ago
Boran Biotechnology Port Stock Exchange announcement: The self-developed Bovolu injection (dulaglutide injection) has obtained market approval from the National Medical Products Administration for blood sugar control in adult type 2 diabetes patients. Bovolu is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist, and its commercialization in mainland China is carried out in cooperation with Shang Yao Holdings by the company.
38 m ago
Stardust Era unveils products such as Stardust L7 at the World Robot Conference.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.